The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Article
in English
| IMSEAR
| ID: sea-39455
ABSTRACT
OBJECTIVE:
To compare the efficacy of combined low dose of hypouricemic drugs (Allopurinol 100 mg and benzbromarone 20 mg; Allomaron) and standard dose 300 mg of allopurinol in hyperuricemia. MATERIAL ANDMETHOD:
A prospective, open study of 94 hyperuricemic patients was done at King Chulalongkorn Memorial Hospital. Each group of 47 patients was given a combined low dose of hypouricemic drugs (Allopurinol 100 mg and benzbromarone 20 mg; Allomaron) and a standard dose 300 mg of allopurinol. Serum uric acid was measured before and 4 weeks after receiving the drugs. The efficacy was measured from the difference of the level of serum uric acid before and after receiving the drugs.RESULTS:
The patients receiving the combined low dose of hypouricemic drugs and standard dose of allopurinol showed a mean reduction of serum uric acid of 2.5+/-3.4 mg/dl and 4.1+/-2.7 mg/dl consecutively. There was a statistically significant difference between the 2 groups (P = 0.010).CONCLUSION:
This study demonstrates that the efficacy of standard dose 300 mg of allopurinol is superior to a combined low dose of allopurinol and benzbromarone in lowering the level of serum uric acid level.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Uric Acid
/
Female
/
Humans
/
Male
/
Benzbromarone
/
Drug Administration Schedule
/
Uricosuric Agents
/
Allopurinol
/
Gout Suppressants
/
Prospective Studies
Type of study:
Observational study
Language:
English
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS